A Stage I pilot study of acceptance and commitment therapy for methadone detoxification

Drug and Alcohol Dependence

Volumn 125, Issue 3, 2012, Pages 215-222

  Stotts, Angela L ^a   Green, Charles ^a   Masuda, Akihiko ^b   Grabowski, John ^c   Wilson, Kelly ^d   Northrup, Thomas F ^a   Moeller, F Gerard ^a   Schmitz, Joy M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Acceptance and commitment therapy; Behavior therapy; Methadone; Mindfulness; Opiate; Opioid dependence; Opioid detoxification; Opioid withdrawal

Indexed keywords

METHADONE;

ABSTINENCE; ACCEPTANCE AND COMMITMENT THERAPY; ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; COUNSELING; DRUG DETOXIFICATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WITHDRAWAL SYNDROME;

ADULT; COUNSELING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEAR; FEMALE; HUMANS; MALE; MENTAL DISORDERS; METABOLIC DETOXICATION, DRUG; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; PILOT PROJECTS; RISK-TAKING; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 84866410360     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.02.015     Document Type: Article

References (45)

1. Substance Abuse Mental Health Services Administration. Office of Applied Studies, 2010. Treatment Episode Data Set Admissions (TEDS-A), 1992 - present. Available from: http://wwwicpsrumichedu/icpsrweb/SAMHDA/series/00056/studies/25221%3FsortBy=7(8202010).
2. Amato L., Davoli M., Ferri M., Gowing L., Perucci C.A. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews. Drug Alcohol Depend. 2004, 73:219-226.
3. Becker W.C., Sullivan L.E., Tetrault J.M., Desai R.A., Fiellin D.A. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008, 94:38-47.
4. Calsyn D.A., Malcy J.A., Saxon A.J. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J. Subst. Abuse Treat. 2006, 30:159-163.
5. Chutuape M.A., Jasinski D.R., Fingerhood M.I., Stitzer M.L. One-, three-, and six-month outcomes after brief inpatient opioid detoxification. Am. J. Drug Alcohol Abuse 2001, 27:19-44.
6. Clausen T., Waal H., Thoresen M., Gossop M. Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction 2009, 104:1356-1362.
7. Compton P., Charuvastra V.C., Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 2001, 63:139-146.
8. Crits-Christoph P., Siqueland L., Blaine J., Frank A., Luborsky L., Onken L.S., Muenz L.R., Thase M.E., Weiss R.D., Gastfriend D.R., Woody G.E., Barber J.P., Butler S.F., Daley D., Salloum I., Bishop S., Najavits L.M., Lis J., Mercer D., Griffin M.L., Moras K., Beck A.T. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch. Gen. Psychiatry 1999, 56:493-502.
9. Dunn K.E., Sigmon S.C., Strain E.C., Heil S.H., Higgins S.T. The association between outpatient buprenorphine detoxifcation duration and clinical treatment outcomes: a review. Drug Alcohol Depend. 2011, 119:1-9.
10. Eklund C., Hiltunen A.J., Melin L., Borg S. Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone. Subst. Use Misuse 1997, 32:779-792.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID -I/P, Version 2.0). 1995, Biometric Research Department, Psychiatric Institute, NY.
12. Fry C., Rumbold G., Lintzeris N. The Blood Borne Virus Transmission Risk Assessment Questionnaire (BBVTRAQ): Administration and Procedures Manual 1998, Turning Point Alcohol and Drug Centre, Melbourne.
13. Gifford E.V., Kohlenberg B.S., Hayes S.C., Antonuccio D.O., Piasecki M.M., Rasmussen-Hall M.L., Palm K.M. Acceptance-based treatment for smoking cessation. Behav. Ther. 2004, 35:689-705.
14. Gossop M., Marsden J., Stewart D., Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2001, 62:255-264.
15. Green C.E., Moeller F.G., Schmitz J.M., Lucke J.F., Lane S.D., Swann A.C., Lasky R.E., Carbonari J.P. Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach. Am. J. Drug Alcohol Abuse 2009, 35:95-102.
16. Gregg J.A., Callaghan G.M., Hayes S.C., Glenn-Lawson J.L. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J. Consult. Clin. Psychol. 2007, 75:336-343.
17. Gruber V.A., Delucchi K.L., Kielstein A., Batki S.L. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008, 94:199-206.
18. Hall S.M., Loeb P.C., Kushner M. Methadone dose decreases and anxiety reduction. Addict. Behav. 1984, 9:11-19.
19. Handelsman L., Cochrane K.J., Aronson M.J., Ness R., Rubinstein K.J., Kanof P.D. Two new rating scales for opiate withdrawal. Am. J. Drug Alcohol Abuse 1987, 13:293-308.
20. Hayes S.C., Luoma J.B., Bond F.W., Masuda A., Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav. Res. Ther. 2006, 44:1-25.
21. Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change 1999, Guilford Press, New York, NY, US.
22. Hayes S.C., Wilson K.G., Gifford E.V., Bissett R., Piasecki M., Batten S.V., Gregg J. A preliminary trial of twelve-step facilitation and acceptance and commitment therapy with polysubstance-abusing methadone-maintained opiate addicts. Behav. Ther. 2004, 35:667-688.
23. Hayes S.C., Wilson K.G., Gifford E.V., Follette V.M., Strosahl K. Experimental avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. J. Consult. Clin. Psychol. 1996, 64:1152-1168.
24. Latowsky M. Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal. J. Psychoactive Drugs 1996, 28:251-257.
25. Lejuez C.W., Paulson A., Daughters S.B., Bornovalova M.A., Zvolensky M.J. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Behav. Res. Ther. 2006, 44:667-677.
26. Ling W., Amass L., Shoptaw S., Annon J.J., Hillhouse M., Babcock D., Brigham G., Harrer J., Reid M., Muir J., Buchan B., Orr D., Woody G., Krejci J., Ziedonis D. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 2005, 100:1090-1100.
27. Lintzeris N., Bell J., Bammer G., Jolley D.J., Rushworth L. A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction 2002, 97:1395-1404.
28. Luoma, J.B., Kohlenberg, B.S., Hayes, S.C., Fletcher, L. Slow and steady wins the race: a randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders. J. Consult. Clin. Psychol. (in press).
29. Magura S., Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt. Sinai J. Med. 2001, 68:62-74.
30. Mannelli P., Patkar A.A., Peindl K., Gorelick D.A., Wu L.T., Gottheil E. Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addict. Biol. 2009, 14:204-213.
31. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The Fifth Edition of the Addiction Severity Index. J. Subst. Abuse Treat. 1992, 9:199-213.
32. Milby J.B., Garrett C., Meredith R. Iatrogenic phobic disorders in methadone maintenance treated patients. Int. J. Addict. 1980, 15:737-747.
33. Milby J.B., Gurwitch R.H., Hohmann A.A., Wiebe D.J., Ling W., Mclellan A.T., Woody G.E. Assessing pathological detoxification fear among methadone-maintenance patients - the DFSS. J. Clin. Psychol. 1987, 43:528-538.
34. Milby J.B., Hohmann A.A., Gentile M., Huggins N., Sims M.K., McLellan A.T., Woody G., Haas N. Methadone maintenance outcome as a function of detoxification phobia. Am. J. Psychiatry 1994, 151:1031-1037.
35. Raudenbush S.W., Bryk A.S. Hierarchical Linear Models 2002, Sage Publications, Thousand Oaks. 2nd edition.
36. SAS Institute, Inc. SAS v. 9.2 2008, SAS Institute, Inc., Cary, NC.
37. Schmitz J.M., Stotts A.L., Rhoades H.M., Grabowski J. Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict. Behav. 2001, 26:167-180.
38. Schmitz J.M., Stotts A.L., Sayre S.L., DeLaune K.A., Rhoades H., Grabowski J. Naltrexone and relapse prevention treatment for cocaine-alcohol dependent patients. Drug Alcohol Depend. 2002, 66(Suppl.):S158.
39. Smout M.F., Longo M., Harrison S., Minniti R., Wickes W., White J.M. Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy. Subst. Abuse 2010, 31:98-107.
40. StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.
41. Stotts A.L., Dodrill C.L., Kosten T.R. Opioid dependence treatment: options in pharmacotherapy. Expert Opin. Pharmacother. 2009, 10:1727-1740.
42. Stotts A.L., Masuda A., Wilson K. Using acceptance and commitment therapy during methadone dose reduction: rationale, treatment description, and a case report. Cogn. Behav. Pract. 2009, 16:205-213.
43. Stotts, A.L., Mooney, M., Herin, D.V., Moody, D.E., Schmitz, J.M., Grabowski, J. Opioid maintenance pharmacotherapy and discontinuation: pharmacological and behavioral therapy strategies. Exp. Clin. Psychopharmacol. (in preparation).
44. Stout R.L., Wirtz P.W., Carbonari J.P., Del Boca F.K. Ensuring balanced distribution of prognostic factors in treatment outcome research. J. Stud. Alcohol Suppl. 1994, 12:70-75.
45. Wijeysundera D., Austin P., Hux J., Beattie W., Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J. Clin. Epidemiol. 2009, 62:13-21. e15.